4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer
PHASE3
The present multi-center, open-label, single-arm study aims to evaluate the...
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
PHASE2
This randomized, open-label, two-arm, multi-center, Phase II study will eva...
Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate
N/A
To provide access to palbociclib to post-menopausal women with HR-positive,...
Status
No Longer Available
Location
CBCC Global Research, Inc. at Comprehensive Blood & Cancer Center Research Center